ClinicalTrials.Veeva

Menu

A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)

Merck Sharp & Dohme (MSD) logo

Merck Sharp & Dohme (MSD)

Status and phase

Completed
Phase 1

Conditions

Metastatic Prostate Cancer

Treatments

Drug: Fludrocortisone
Drug: [¹⁴C]Opevesostat
Drug: Prednisone

Study type

Interventional

Funder types

Industry

Identifiers

NCT06566989
MK-5684-008 (Other Identifier)
5684-008
1010197 (Registry Identifier)

Details and patient eligibility

About

This is a study of opevesostat in healthy adult male participants. The purpose of this study is to understand the absorption, distribution, metabolism, and elimination of opevesostat in humans, as well as its pharmacokinetics (PK), metabolic profile, and safety and tolerability.

Enrollment

8 patients

Sex

Male

Ages

30 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Is a healthy male according to the assessment of the investigator
  • Has a body mass index of 18.0 to 32.0 kg/m2
  • Has regular bowel movements (i.e., average stool production of ≥1 and ≤3 stools per day)

Exclusion criteria

  • Has the presence or history of clinically significant allergy requiring treatment
  • Has a history of adrenal insufficiency
  • Has veins not suitable for multiple venipunctures/cannulation
  • Has previously taken part in more than 3 radiolabeled drug studies in the last 12 months
  • Has donated blood or plasma within the previous 3 months or lost greater than 400 mL of blood

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

8 participants in 1 patient group

[¹⁴C]Opevesostat
Experimental group
Description:
On Day 1, participants receive a single dose of \[¹⁴C\]opevesostat as an oral solution. Participants then receive single doses of 5.0 mg prednisone and 0.05 mg fludrocortisone tablets 4 hours later as hormone replacement therapy.
Treatment:
Drug: Prednisone
Drug: [¹⁴C]Opevesostat
Drug: Fludrocortisone

Trial contacts and locations

1

Loading...

Central trial contact

Toll Free Number

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems